Offer - Urjas Oil for just ₹ 1
Arbitel-MT 25 Tablet ER is a prescription medicine that is available as a Tablet. Secondary and off-label uses of Arbitel-MT 25 Tablet ER have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Arbitel-MT 25 Tablet ER. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Arbitel-MT 25 Tablet ER also has some side effects, the most common being Headache, Dizziness, Weakness. While these are the most often observed Arbitel-MT 25 Tablet ER side effects, there are can be others also. These have been listed below. These side effects of Arbitel-MT 25 Tablet ER are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Arbitel-MT 25 Tablet ER's effect is Severe during pregnancy and Safe for lactating mothers. It is important to know if Arbitel-MT 25 Tablet ER has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Arbitel-MT 25 Tablet ER related warnings section.
Arbitel-MT 25 Tablet ER can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Arbitel-MT 25 Tablet ER in conditions like Diabetes, Congestive Heart Failure (CHF), Angioedema.
Drug reaction of Arbitel-MT 25 Tablet ER with other medicines has been reported. A complete list of these interactions is given below.
You should also be aware that Arbitel-MT 25 Tablet ER is not safe while driving, and is not addiction.
Arbitel-MT 25 Tablet ER is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Is the use of Arbitel-MT 25 Tablet ER safe for pregnant women?
Arbitel- MT has many dangerous side effects in pregnant women. If you are pregnant, do not consume Arbitel- MT without medical advice.
Is the use of Arbitel-MT 25 Tablet ER safe during breastfeeding?
Arbitel- MT does not show any harmful effects in lactating women.
What is the effect of Arbitel-MT 25 Tablet ER on the Kidneys?
Arbitel- MT may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Arbitel-MT 25 Tablet ER on the Liver?
You may experience side effects on your liver after taking Arbitel- MT. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Arbitel-MT 25 Tablet ER on the Heart?
Arbitel- MT is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Arbitel-MT 25 Tablet ER unless your doctor advises you to do so -
Is this Arbitel-MT 25 Tablet ER habit forming or addictive?
Forming a habit of Arbitel-MT 25 Tablet ER has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Arbitel-MT 25 Tablet ER, you should not drive or work on any heavy machine, as Arbitel-MT 25 Tablet ER can make you drowsy.
Is it safe?
Yes, but consume Arbitel-MT 25 Tablet ER only on doctor's advice.
Is it able to treat mental disorders?
No, Arbitel-MT 25 Tablet ER cannot treat any kind of mental disorder.
Interaction between Food and Arbitel-MT 25 Tablet ER
Due to the absence of research, it is difficult to say how Arbitel-MT 25 Tablet ER and food will interact.
Interaction between Alcohol and Arbitel-MT 25 Tablet ER
It is difficult to say anything about the effect of Arbitel-MT 25 Tablet ER and alcohol. No research has been done on this yet.
Arbitel- MT can be taken as long as it is prescribed by your doctor. You must not discontinue taking it even when you start feeling well. In addition, you must not take it more frequently as that can have adverse effects. Follow the recommendations of your doctor completely.
No, Arbitel- MT doesn't cause depression. However, if you experience depression while taking Arbitel- MT, please talk to your doctor immediately.
No, Arbitel- MT does not cause weight gain. Weight gain has rarely been associated with this drug. However, if you are experiencing unusual weight gain and you are in doubt that Arbitel- MT is causing weight gain then discuss with your doctor instantly.
Arbitel- MT is available in the form of tablets. A tablet is usually taken once a day, with or without food because food affects the absorption of this drug. It should be taken at exactly the same time every time to avoid skipping the dose. Arbitel- MT might start showing the effects between 2 to 4 weeks, therefore, it is important to continue taking it even when you feel well. One should take Arbitel- MT exactly as prescribed by their doctor.
No, Arbitel- MT is not bad for kidneys. In fact, it protects the kidneys, thus, it is suitable for people with diabetes and mild-to-moderate kidney disease.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
